Questionnaires can be a good predictor of survival rates in multiple sclerosis

July 10, 2017, Imperial College London
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

The way in which patients with multiple sclerosis answer questionnaires could help to predict their survival rate from the disease, a study has found.

The research, carried out at Imperial College London in collaboration with University Medical Centre Göttingen, shows that MS with higher scores on a standardised were more likely to die in the next 10 years compared to those who recorded lower scores.

Researchers believe the study is the first to show that such patient-reported outcomes, captured by simple questionnaires, can be used to predict clinical outcomes in neurological diseases, like MS.

They stress that while these tools cannot yet be used to accurately predict individual patients' survival, at a group level they could help to compare the effectiveness of treatment options, and tailor healthcare to an individual's needs.

"Our research shows that by answering a set series of questions, patients can have an important role in predicting long-term prognosis in diseases like MS, and that these types of questionnaire should be used by doctors to get a better idea of the patient's health," said Dr Joel Raffel, from the Department of Medicine and who led the research, published today in PLOS Medicine.

MS is a degenerative affecting the central nervous system. It is caused by the immune cells turning on the nerves and damaging the fatty layer of insulation which protects them, leading to a range of symptoms. The condition affects an estimated 100,000 people in the UK, with patients normally diagnosed between the ages of 20 to 40. As MS is a complex and highly variable disease it can vary from one person to the next, making it difficult to give patients an accurate prognosis on how their disease will progress.

In the study, patients completed a standardised questionnaire which graded to what degree their symptoms impacted on their lives. The impact scale (MSIS-29) asks patients a series of 29 questions to find out how their MS has affected them in the previous two weeks. It uses a scale from one to five—with five being most affected.

A total of 2,126 patients registered with the UK Multiple Sclerosis Society Tissue Bank completed the questionnaire in 2004, with 872 of this group completing a second survey one year later. Within 10 years, 264 of the original patient group had died.

Researchers found that those patients who scored highest on questions relating to physical health - i.e. 'In the past two weeks, how much has your MS limited your ability to carry things?'—were 5.7 times more likely to die from the disease within 10 years, compared with the lowest scoring patients. What's more, mortality risk was 2.2 times higher still in those whose score increased on their second questionnaire, compared to those with a stable or decreasing score.

According to Dr Raffel, adding a tool like the MSIS-29 questionnaire to clinical assessments can help patients tell their doctor how MS is affecting their quality of life, giving more insight into how the disease is progressing and how their prognosis is changing over time.

"Traditionally, in medicine, doctors will decide if a patient is getting better or worse," explained Dr Raffel. "We hope that using patient-reported outcomes like these more and more will mean a shift towards empowering patients. They will be able to provide their own data, so rather than the doctor telling the patient how they are doing, it's the other way around. What's more the questionnaire can be completed online and not in the presence of a doctor."

The researchers highlight that the study had limitations, with most patients involved being in the later stages of disease. For those with early-stage MS, the disease often has a lesser physical impact, which might make the questionnaire less predictive of future outcomes.

The hope is that patient-reported outcomes could be another tool to add to the clinical toolkit used by doctors to assess patients. Incorporating questionnaire responses, which can be easily filled out by patients online, with imaging data such as MRI scans and other clinical assessments, could help the doctor and patient to choose the best course of treatment.

Dr Raffel added: "Ideally, these questionnaires should be administered routinely, once a year in the clinic or online. This could help to understand what issues the patients are facing and could also help to answer big research questions around prognosis and which of the available treatments we have for MS are working."

Explore further: Persistent pain shows up inefficiency of current psoriatic arthritis (PsA) treatment

More information: Joel Raffel et al, Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29, PLOS Medicine (2017). DOI: 10.1371/journal.pmed.1002346

Related Stories

Persistent pain shows up inefficiency of current psoriatic arthritis (PsA) treatment

June 15, 2017
The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have highlighted limitations in the current treatment of patients with Psoriatic Arthritis (PsA).

Assessing the impact of stress in age-related macular degeneration

March 3, 2017
Age-related macular degeneration (AMD), the leading cause of vision loss among older adults in the United States, is often associated with psychological stress. A simple stress rating scale (the Perceived Stress Scale) is ...

Patients nearing end of life receptive to having cholesterol medicine 'deprescribed'

June 2, 2017
New research suggests patients nearing the end of their lives because of a "life-limiting illness" such as cancer or heart disease may not feel medically abandoned if their doctor wants to take them off the statins that control ...

Minority colorectal cancer patients report higher burden of poor quality-of-life

March 27, 2017
A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that Hispanics and blacks had a higher burden of poor health-related quality-of-life (HR-QoL) ...

RA disease activity score most influential in patient reports

November 10, 2016
(HealthDay)—Higher disease activity score (DAS) is one of the most influential factors for poor patient-reported outcomes (PROs) in rheumatoid arthritis (RA), according to a study published online Nov. 5 in the International ...

Patient reported outcome measurement system (PROMIS) valid in assessing patient experience

November 7, 2015
A study at Hospital for Special Surgery (HSS) evaluating the Patient Reported Outcomes Measurement Information System (PROMIS) in patients with lupus finds that the questionnaire is valid in assessing subjective patient experience. ...

Recommended for you

Researchers decipher the genome in chronic lymphocytic leukaemia

May 23, 2018
A team of researchers from University of Barcelona (UB) and their collaborators report for the first time the complete epigenome of chronic lymphocytic leukaemia, the most common type of leukaemia. The study, published in ...

Scientists discover how breast cancer hibernates: study

May 22, 2018
Scientists have identified the mechanism that allows breast cancer cells to lie dormant in other parts of the body only to reemerge years later with lethal force, according to a study published Tuesday.

Researcher: Big data, networks identify cell signaling pathways in lung cancer

May 22, 2018
A team of scientists led by University of Montana cell biologist Mark Grimes has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.

Downward-facing mouse: Stretching reduces tumor growth in mouse model of breast cancer

May 22, 2018
Many cancer patients seek out gentle, movement-based stretching techniques such as yoga, tai chi and qigong, but does stretching have an effect on cancer? While many animal studies have attempted to quantify the effects of ...

Resetting the epigenetic balance for cancer therapy

May 22, 2018
Though mutations in a gene called MLL3 are common across many types of cancers, their relationship to the development of the disease has been unclear. Now, a Northwestern Medicine study has identified an epigenetic imbalance ...

Compound in citrus oil could reduce dry mouth in head, neck cancer patients

May 21, 2018
A compound found in citrus oils could help alleviate dry mouth caused by radiation therapy in head and neck cancer patients, according to a new study by researchers at the Stanford University School of Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.